Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 13 results.
User Information
Export Records
  1. 1.   Use of Patient-specific MRI-based Prostate Mold for Validation of Multiparametric MRI in Localization of Prostate Cancer
  2. Trivedi, H.; Turkbey, B.; Rastinehad, A. R.; Benjamin, C. J.; Bernardo, M.; Pohida, T.; Shah, V.; Merino, M. J.; Wood, B. J.; Linehan, W. M.; Venkatesan, A. M.; Choyke, P. L.; Pinto, P. A.
  3. Urology. 2012, Jan; 79(1): 233-239.
  1. 2.   MRI of localized prostate cancer: coming of age in the PSA era
  2. Turkbey, B.; Bernardo, M.; Merino, M. J.; Wood, B. J.; Pinto, P. A.; Choyke, P. L.
  3. Diagnostic and Interventional Radiology. 2012, Jan-Feb; 18(1): 34-45.
  1. 3.   Is Apparent Diffusion Coefficient Associated with Clinical Risk Scores for Prostate Cancers that Are Visible on 3-T MR Images ?
  2. Turkbey, B.; Shah, V. P.; Pang, Y. X.; Bernardo, M.; Xu, S.; Kruecker, J.; Locklin, J.; Baccala, A. A.; Rastinehad, A. R.; Merino, M. J.; Shih, J. H.; Wood, B. J.; Pinto, P. A.; Choyke, P. L.
  3. Radiology. 2011, Feb; 258(2): 488-495.
  1. 4.   Systematic Proteome Analysis Identifies Transcription Factor YY1 as a Direct Target of miR-34a
  2. Chen, Q. R.; Yu, L. R.; Tsang, P.; Wei, J. S.; Song, Y. K.; Cheuk, A.; Chung, J. Y.; Hewitt, S. M.; Veenstra, T. D.; Khan, J.
  3. Journal of Proteome Research. 2011, Feb; 10(2): 479-487.
  1. 5.   Conformational ensembles, signal transduction and residue hot spots: Application to drug discovery
  2. Ozbabacan, S. E. A.; Gursoy, A.; Keskin, O.; Nussinov, R.
  3. Current Opinion in Drug Discovery & Development. 2010, Sep; 13(5): 527-537.
  1. 6.   Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar soft part sarcoma
  2. Vistica, D. T.; Krosky, P. M.; Kenney, S.; Raffeld, M.; Shoemaker, R. H.
  3. Journal of Pediatric Hematology Oncology. 2008 30(1): 46-52.
  1. 7.   Dynamic contrast-enhanced MRI of prostate cancer at 3 T: A study of pharmacokinetic parameters
  2. Ocak, I.; Bernardo, M.; Metzger, G.; Barrett, T.; Pinto, P.; Albert, P. S.; Choyke, P. L.
  3. American Journal of Roentgenology. 2007, Oct; 189(4): W192-W201.
  1. 8.   Trp/Met/Phe hot spots in protein-protein interactions: Potential targets in drug design
  2. Ma, B.; Nussinov, R.
  3. Current Topics in Medicinal Chemistry. 2007 7(10): 999-1005.
  1. 9.   Comparison of the protein-protein interfaces in the p53-DNA crystal structures: Towards elucidation of the biological interface
  2. Ma, B. Y.; Pan, Y. P.; Gunasekaran, K.; Venkataraghavan, R. B.; Levine, A. J.; Nussinov, R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, MAR 15; 102(11): 3988-3993.
  1. 10.   Epigenetic and gene expression changes related to transgenerational carcinogenesis
  2. Cheng, R. Y. S.; Hockman, T.; Crawford, E.; Anderson, L. M.; Shiao, Y. H.
  3. Molecular Carcinogenesis. 2004 40(1): 1-11.
  1. 11.   The neutrophil granule protein cathepsin G activates murine T lymphocytes and upregulates antigen-specific Ig production in mice
  2. Tani, K.; Murphy, W. J.; Chertov, O.; Oppenheim, J. J.; Wang, J. M.
  3. Biochemical and Biophysical Research Communications. 2001 282(4): 971-976.
  1. 12.   Mdm2 binds p73 alpha without targeting degradation
  2. Balint, E.; Bates, S.; Vousden, K. H.
  3. Oncogene. 1999 18(27): 3923-3929.
  1. 13.   What can we learn about age-related macular degeneration from other retinal diseases?
  2. Zack, D. J.; Dean, M.; Molday, R. S.; Nathans, J.; Redmond, T. M.; Stone, E. M.; Swaroop, A.; Valle, D.; Weber, B. H. F.
  3. Molecular Vision. 1999 5(24-35): NIL_37-NIL_43.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel